Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Melanoma Research|January 3, 2020
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)Elisa A Rozeman, Warner Prevoo, Mark A J Meier, et al.The Journal of Pathology|July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practiceKris G Samsom, Luuk J Schipper, Paul Roepman, et al.The British Journal of Surgery|June 6, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trialLiselotte Tas, Marie B Weitemeyer, Maartje W Rohaan, et al.Nature Cancer|September 28, 2020
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Noushin Niknafs, Kristen Marrone, et al.Nature Protocols|December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceKris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.Physics and Imaging in Radiation Oncology|March 30, 2026
Recommendations for contouring of gross tumour volume for locally advanced lung cancer using magnetic resonance imagingAnna-Maria Shiarli, Michael J Dubec, Merina Ahmed, et al.Nature Medicine|May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.Nature Medicine|June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.Pageof 3